Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)

SHE:002262 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 12, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	25,252	24,744	27,326	24,736	15,769	16,092
Market Cap Growth	-3.64%	-9.45%	10.47%	56.87%	-2.01%	35.74%
Enterprise Value	21,304	20,984	23,972	21,956	13,322	13,929
Last Close Price	24.86	23.96	26.33	23.67	14.85	15.06
PE Ratio	20.53	21.64	26.35	27.46	19.77	22.08
Forward PE	20.05	18.59	22.41	24.31	17.58	18.30
PS Ratio	4.19	4.34	5.42	5.76	4.01	4.79
PB Ratio	3.13	3.40	4.26	4.43	3.22	3.92
P/TBV Ratio	3.21	3.50	4.38	4.49	3.27	4.00
P/FCF Ratio	49.22	53.09	43.08	46.39	31.86	16.43
P/OCF Ratio	27.57	27.01	27.10	28.73	22.49	12.89
PEG Ratio	1.54	1.09	1.02	1.35	0.87	0.87
EV/Sales Ratio	3.54	3.68	4.76	5.11	3.39	4.14
EV/EBITDA Ratio	14.49	15.38	19.90	21.43	13.88	15.86
EV/EBIT Ratio	16.68	17.30	22.41	24.35	15.72	17.82
EV/FCF Ratio	41.53	45.02	37.79	41.17	26.91	14.22
Debt / Equity Ratio	0.01	0.01	0.02	0.02	0.02	0.01
Debt / EBITDA Ratio	0.03	0.05	0.09	0.09	0.11	0.04
Debt / FCF Ratio	0.09	0.15	0.18	0.17	0.22	0.04
Asset Turnover	0.70	0.72	0.73	0.71	0.75	0.75
Inventory Turnover	1.98	2.40	2.09	1.57	1.80	2.16
Quick Ratio	6.24	5.00	5.64	4.88	5.01	4.99
Current Ratio	7.29	5.68	6.46	5.86	5.93	5.77
Return on Equity (ROE)	16.19%	16.67%	17.25%	16.78%	17.72%	18.86%
Return on Assets (ROA)	9.28%	9.62%	9.68%	9.25%	10.14%	10.91%
Return on Capital (ROIC)	10.41%	10.94%	10.96%	10.54%	11.56%	12.55%
Return on Capital Employed (ROCE)	15.60%	16.50%	16.40%	15.90%	16.90%	18.70%
Earnings Yield	4.87%	4.62%	3.79%	3.64%	5.06%	4.53%
FCF Yield	2.03%	1.88%	2.32%	2.16%	3.14%	6.09%
Dividend Yield	1.47%	1.50%	1.21%	0.84%	1.35%	0.66%
Payout Ratio	29.81%	28.31%	19.54%	22.51%	12.63%	13.98%
Buyback Yield / Dilution	-0.61%	-0.53%	0.53%	-0.22%	0.24%	-0.72%
Total Shareholder Return	0.86%	0.98%	1.74%	0.63%	1.58%	-0.06%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.